Cargando…
Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis
RNAi-based bone anabolic gene therapy has demonstrated initial success, but many practical challenges are still unmet. Here, we demonstrate that a recombinant adeno-associated virus 9 (rAAV9) is highly effective for transducing osteoblast lineage cells in the bone. The adaptor protein Schnurri-3 (SH...
Autores principales: | Yang, Yeon-Suk, Xie, Jun, Wang, Dan, Kim, Jung-Min, Tai, Phillip W. L., Gravallese, Ellen, Gao, Guangping, Shim, Jae-Hyuck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609711/ https://www.ncbi.nlm.nih.gov/pubmed/31273195 http://dx.doi.org/10.1038/s41467-019-10809-6 |
Ejemplares similares
-
Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy
por: Yang, Yeon-Suk, et al.
Publicado: (2020) -
Schnurri-3 inhibition suppresses bone and joint damage in models of rheumatoid arthritis
por: Stavre, Zheni, et al.
Publicado: (2023) -
AAV-mediated delivery of osteoblast/osteoclast-regulating miRNAs for osteoporosis therapy
por: John, Aijaz Ahmad, et al.
Publicado: (2022) -
Biomechanical and Bone Material Properties of Schnurri‐3 Null Mice
por: Hofstaetter, Jochen G, et al.
Publicado: (2019) -
AAV-Mediated Targeting of the Activin A-ACVR1(R206H) Signaling in Fibrodysplasia Ossificans Progressiva
por: Yang, Yeon-Suk, et al.
Publicado: (2023)